Denosumab and incidence of type 2 diabetes among adults with osteoporosis: population based cohort study is a dataset published in BMJ (2023). On theSindex it has a DataRank of 1.5, placing it in the top 13.9% of the data-sharing corpus. It has been cited 63 times, with 55 citing works in its 1-hop citation network. Its calibrated FAIR score is 4/100.
Ranks in the top 14% for downstream scientific impact
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
Full FAIR picture · advisory
The headline score is computed from the scored criteria — the fact-shaped checks (a repository, an accession, a licence) that two independent models agree on. The advisory criteria below are real FAIR guidance but rest on judgment calls that models read differently, so they inform without moving the number.
“f_dataset_pid”— not found in the paper; verdict downgraded
No persistent identifier is provided for the study's own dataset.
RDA-F1-01D — FAIR Data Maturity Model: 'Data is identified by a persistent identifier' (priorit · RDA-F1-02D — FAIR Data Maturity Model: 'Data is identified by a globally unique identifier' · FsF-F1-02D — F-UJI/FAIRsFAIR: 'Data is assigned a persistent identifier'
“f_repository_named”— not found in the paper; verdict downgraded
No repository is named as the holder of the study's data.
RDA-F4-01M — FAIR Data Maturity Model: metadata is offered so it can be harvested and indexed ( · NIH DMS Policy Element 4 (NOT-OD-21-014) — name the repository where data will be archived · NSTC Desirable Characteristics of Data Repositories (2022) — 'Long-Term Sustainability', 'Reten
“f_dataset_cited”— not found in the paper; verdict downgraded
No identifier for the dataset appears anywhere in the paper.
FORCE11 Joint Declaration of Data Citation Principles (2014) — data should be cited as a first- · RDA-F3-01M — metadata clearly and explicitly includes the identifier of the data it describes · FsF-F3-01M — F-UJI: 'Metadata includes the identifier of the data it describes'
Advisory · not in the published score
“f_data_availability_statement”— not found in the paper; verdict downgraded
The data availability statement says 'No additional data available' and points to a third-party website for the original database, not the study's own data.
Colavizza, Hrynaszkiewicz, Staden, Whitaker & McGillivray (2020), 'The citation advantage of li · Springer Nature research data policy — Data Availability Statements: standard statement templat · RDA-F3-01M — metadata clearly and explicitly includes the identifier of the data it describes
“f_discovery_metadata”— not found in the paper; verdict downgraded
No itemized inventory of the dataset is provided.
RDA-F2-01M — 'Rich metadata is provided to allow discovery' (priority Essential) · FsF-F2-01M — F-UJI: 'Metadata includes descriptive core elements to support data findability' · FsF-R1-01MD — F-UJI: 'Metadata specifies the content of the data'
“a_data_openly_accessible”— not found in the paper; verdict downgraded
The paper does not provide a dataset identifier, repository, or data availability statement pointing to the study's own data; the data are not accessible, and no documentation or licensing is provided.
RDA-A1.1-01D — 'Data is accessible through a free access protocol' · FsF-A1-01M — F-UJI: 'Metadata contains access level and access conditions of the data' · NSTC Desirable Characteristics of Data Repositories (2022) — 'Free and Easy Access'
Advisory · not in the published score
“a_data_openly_accessible”— not found in the paper; verdict downgraded
The paper does not provide a dataset identifier, repository, or data availability statement pointing to the study's own data; the data are not accessible, and no documentation or licensing is provided.
FsF-A1-01M — F-UJI: 'Metadata contains access level and access conditions of the data' · RDA-A1-01M — metadata contains information to enable the user to get access to the data · COAR Controlled Vocabularies — Access Rights v1.0 (open / embargoed / restricted / metadata-onl
“a_data_openly_accessible”— not found in the paper; verdict downgraded
The paper does not provide a dataset identifier, repository, or data availability statement pointing to the study's own data; the data are not accessible, and no documentation or licensing is provided.
NIH Genomic Data Sharing Policy (NOT-OD-14-124) — controlled-access via a Data Access Committee · RDA-A1.2-01D — 'Data is accessible through an access protocol that supports authentication and · NIH DMS Policy Element 5 (NOT-OD-21-014) — Access, Distribution, or Reuse Considerations (conse
“a_data_openly_accessible”— not found in the paper; verdict downgraded
The paper does not provide a dataset identifier, repository, or data availability statement pointing to the study's own data; the data are not accessible, and no documentation or licensing is provided.
NIH DMS Plan Element 4 (NOT-OD-21-014) — Data Preservation, Access, and Associated Timelines · NSTC Desirable Characteristics (2022), Organizational Infrastructure: 'Retention Policy' · RDA-A2-01M — 'Metadata is guaranteed to remain available after data is no longer available'
“i_open_nonproprietary_format”— not found in the paper; verdict downgraded
No file format is named for the released data.
FsF-R1.3-02D — F-UJI: 'Data is available in a file format recommended by the target research co · RDA-R1.3-02D — data is expressed in a machine-understandable community standard · RDA-I1-01D — data uses a knowledge representation expressed in a standardised format
Advisory · not in the published score
“i_community_standard_vocabulary”— not found in the paper; verdict downgraded
No community data standard is named.
RDA-R1.3-01M — 'Metadata complies with a community standard' (priority Essential) · RDA-R1.3-01D — 'Data complies with a community standard' · RDA-I2-01M — '(Meta)data use vocabularies that follow FAIR principles'
“i_qualified_references”— not found in the paper; verdict downgraded
No identifier is given for any external resource.
RDA-I3-01M — '(meta)data include references to other (meta)data' · RDA-I3-03M — 'metadata includes qualified references to other metadata' · FsF-I3-01M — F-UJI: 'Metadata includes links between the data and its related entities'
“r_reuse_license”— not found in the paper; verdict downgraded
No license is named for the data; the article license is not applicable.
RDA-R1.1-01M — 'Metadata includes information about the licence under which the data can be reu · RDA-R1.1-02M — 'Metadata refers to a standard reuse licence' · RDA-R1.1-03M — 'Metadata refers to a machine-understandable reuse licence'
“r_versioning”— not found in the paper; verdict downgraded
No version token or date is given for the dataset. [majority verdict 'no' (4/5 passes agreed)]
DataCite Metadata Schema 4.6 — the 'Version' property · RDA-R1.2-01M — provenance information (which version was used is provenance) · NSTC Desirable Characteristics of Data Repositories (2022) — 'Provenance', 'Retention Policy'
“x_code_availability”— not found in the paper; verdict downgraded
No code location is provided.
NIH DMS Policy Element 2 (NOT-OD-21-014) — 'Related Tools, Software and/or Code' · FAIR4RS Principles v1.0 (Chue Hong et al., 2022; RDA/FORCE11/ReSA) — FAIR Principles for Resear · FORCE11 Software Citation Principles (Smith, Katz & Niemeyer, 2016, PeerJ CS 2:e86)
“DHS is supported by the National Institutes of Health (NIH, P30 AR072577).”
The paper lists multiple grant numbers, including P30 AR072577, for the work. [majority verdict 'yes' (4/5 passes agreed)]
DataCite Metadata Schema 4.6 — 'FundingReference' property (funderName, funderIdentifier, award · Crossref Funder Registry — canonical funder identifiers for funding metadata · RDA-F2-01M — rich metadata provided to allow discovery (funding is part of the descriptive reco
Advisory · not in the published score
The paper does not name any specific instrument, kit, or software used to produce its own data (it uses existing data). [majority verdict 'no' (3/5 passes agreed)]
RDA-R1.2-01M — 'Metadata includes provenance information according to community- specific standa · FsF-R1.2-01M — F-UJI: 'Metadata includes provenance information about data creation or generati · W3C PROV-O (W3C Recommendation, 2013) — the entity/activity/agent model of provenance
“r_documentation_codebook”— not found in the paper; verdict downgraded
No documentation object is mentioned. [majority verdict 'no' (4/5 passes agreed)]
RDA-R1-01M — '(Meta)data are richly described with a plurality of accurate and relevant attribu · FsF-R1-01MD — F-UJI: 'Metadata specifies the content of the data' · NIH DMS Policy Element 3 (NOT-OD-21-014) — Standards (documentation and metadata to accompany t
Calibrated FAIR score — a parallel quality metric, independent of the DataRank citation score. See the full evaluation →
Base Score Contribution
0.624
From this paper's citation signal
Citation Network Contribution
0.873
From 36 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 55 citers.
National Institutes of Health
Grant: 3K23AR075070-02S1
Studying pseudogout using natural language processing and novel imaging approaches
National Institutes of Health
Grant: 5P30AR072577-05
VERITY: Value and Evidence in Rheumatology using bioInformaTics, and advanced analYtics
National Institutes of Health
National Natural Science Foundation of China
FWCI
7.04
Citation Percentile
1.0%
Influential Citations
4
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals
Additional file 1 of Effect of denosumab on glucose metabolism in postmenopausal osteoporotic women with prediabetes: a study protocol for a 12-month multicenter, open-label, randomized controlled trial
Additional file 1 of Effect of denosumab on glucose metabolism in postmenopausal osteoporotic women with prediabetes: a study protocol for a 12-month multicenter, open-label, randomized controlled trial
Additional file 2 of Effect of denosumab on glucose metabolism in postmenopausal osteoporotic women with prediabetes: a study protocol for a 12-month multicenter, open-label, randomized controlled trial
Additional file 2 of Effect of denosumab on glucose metabolism in postmenopausal osteoporotic women with prediabetes: a study protocol for a 12-month multicenter, open-label, randomized controlled trial